UNI-MB - logo
UMNIK - logo
 
E-viri
Recenzirano Odprti dostop
  • Cross-species oncogenic sig...
    Kim, Tae-Min; Yang, In Seok; Seung, Byung-Joon; Lee, Sejoon; Kim, Dohyun; Ha, Yoo-Jin; Seo, Mi-Kyoung; Kim, Ka-Kyung; Kim, Hyun Seok; Cheong, Jae-Ho; Sur, Jung-Hyang; Nam, Hojung; Kim, Sangwoo

    Nature communications, 07/2020, Letnik: 11, Številka: 1
    Journal Article

    Genomic and precision medicine research has afforded notable advances in human cancer treatment, yet applicability to other species remains uncertain. Through whole-exome and transcriptome analyses of 191 spontaneous canine mammary tumors (CMTs) that exhibit the archetypal features of human breast cancers, we found a striking resemblance of genomic characteristics including frequent PIK3CA mutations (43.1%), aberrations of the PI3K-Akt pathway (61.7%), and key genes involved in cancer initiation and progression. We also identified three gene expression-based CMT subtypes, one of which segregated with basal-like human breast cancer subtypes with activated epithelial-to-mesenchymal transition, low claudin expression, and unfavorable disease prognosis. A relative lack of ERBB2 amplification and Her2-enrichment subtype in CMT denoted species-specific molecular mechanisms. Taken together, our results elucidate cross-species oncogenic signatures for a better understanding of universal and context-dependent mechanisms in breast cancer development and provide a basis for precision diagnostics and therapeutics for domestic dogs.